How Dr. Reddy’s gets ready for market.
As a generic drug maker, Dr. Reddy’s Laboratories in India must develop new products that are safe, pure, and efficacious. They also need to get those drugs to market quickly. That’s a lot to get ready for. Fortunately, Dr. Reddy’s Laboratories faces this ongoing challenge with the confidence that comes with owning ACQUITY UPLC systems from Waters.
By eliminating significant time and cost per sample from the analytical process while actually improving the quality of the results, ACQUITY UPLC has significantly changed Dr. Reddy’s to-market process. Their QC scientists have found UPLC technology, which has been universally adopted, to be a highly robust, dependable, and reproducible system, due in large part to the patented sub-2-μm hybrid particle chemistry. It’s not just analytical time but processing time that has been saved. And that is how Dr. Reddy’s gets products ready for market.